Ansuvimab

id

WikiRank.net
ver. 1.6.2

Ansuvimab

Quality:

MAb114 - monoclonal antibody that is being trialed as a treatment for Ebola virus disease. Article “Ansuvimab” in Indonesian Wikipedia has 24.8 points for quality (as of July 1, 2025). The article contains 11 references and 1 sections.

This article has the best quality in Chinese Wikipedia. However, the most popular language version of this article is English.

Since the creation of article “Ansuvimab”, its content was written by 1 registered users of Indonesian Wikipedia and edited by 55 registered Wikipedia users in all languages.

The highest Authors Interest rank from 2001:

  • Local (Indonesian): #7187 in February 2025
  • Global: #50445 in August 2019

The highest popularity rank from 2008:

  • Local (Indonesian): #358988 in February 2025
  • Global: #328174 in March 2020

There are 7 language versions for this article in the WikiRank database (of the considered 55 Wikipedia language editions).

The quality and popularity assessment was based on Wikipédia dumps from July 1, 2025 (including revision history and pageviews for previous years).

The table below shows the language versions of the article with the highest quality.

Languages with the highest quality

#LanguageQuality gradeQuality score
1Chinese (zh)
安舒韦单抗
63.2948
2English (en)
Ansuvimab
58.3243
3French (fr)
Ansuvimab
26.5261
4Indonesian (id)
Ansuvimab
24.8215
5Italian (it)
Ansuvimab
22.7155
6Arabic (ar)
أنسوفيماب
22.6625
7Spanish (es)
Ansuvimab
21.682
More...

The following table shows the most popular language versions of the article.

Most popular in all the time

The most popular language versions of the article "Ansuvimab" in all the time
#LanguagePopularity awardRelative popularity
1English (en)
Ansuvimab
59 436
2Chinese (zh)
安舒韦单抗
487
3Italian (it)
Ansuvimab
210
4Arabic (ar)
أنسوفيماب
124
5Spanish (es)
Ansuvimab
53
6French (fr)
Ansuvimab
41
7Indonesian (id)
Ansuvimab
28
More...

The following table shows the language versions of the article with the highest popularity in the last month.

Most popular in June 2025

The most popular language versions of the article "Ansuvimab" in June 2025
#LanguagePopularity awardRelative popularity
1English (en)
Ansuvimab
348
2Chinese (zh)
安舒韦单抗
69
3Italian (it)
Ansuvimab
20
4Spanish (es)
Ansuvimab
10
5French (fr)
Ansuvimab
8
6Indonesian (id)
Ansuvimab
8
7Arabic (ar)
أنسوفيماب
3
More...

The following table shows the language versions of the article with the highest Authors’ Interest.

The highest AI

Language versions of the article "Ansuvimab" with the highest Authors Interest (number of authors). Only registered Wikipedia users were taken into account.
#LanguageAI awardRelative AI
1English (en)
Ansuvimab
34
2Italian (it)
Ansuvimab
11
3French (fr)
Ansuvimab
3
4Arabic (ar)
أنسوفيماب
2
5Spanish (es)
Ansuvimab
2
6Chinese (zh)
安舒韦单抗
2
7Indonesian (id)
Ansuvimab
1
More...

The following table shows the language versions of the article with the highest Authors’ Interest in the last month.

The highest AI in June 2025

Language versions of the article "Ansuvimab" with the highest AI in June 2025
#LanguageAI awardRelative AI
1French (fr)
Ansuvimab
1
2Italian (it)
Ansuvimab
1
3Arabic (ar)
أنسوفيماب
0
4English (en)
Ansuvimab
0
5Spanish (es)
Ansuvimab
0
6Indonesian (id)
Ansuvimab
0
7Chinese (zh)
安舒韦单抗
0
More...

The following table shows the language versions of the article with the highest number of citations.

The highest CI

Language versions of the article "Ansuvimab" with the highest Citation Index (CI)
#LanguageCI awardRelative CI
1English (en)
Ansuvimab
154
2Chinese (zh)
安舒韦单抗
24
3Arabic (ar)
أنسوفيماب
12
4Spanish (es)
Ansuvimab
1
5French (fr)
Ansuvimab
0
6Indonesian (id)
Ansuvimab
0
7Italian (it)
Ansuvimab
0
More...

Scores

Estimated value for Wikipedia:
Indonesian:
Global:
Popularity in June 2025:
Indonesian:
Global:
Popularity in all years:
Indonesian:
Global:
Authors in June 2025:
Indonesian:
Global:
Registered authors in all years:
Indonesian:
Global:
Citations:
Indonesian:
Global:

Quality measures

Interwikis

#LanguageValue
arArabic
أنسوفيماب
enEnglish
Ansuvimab
esSpanish
Ansuvimab
frFrench
Ansuvimab
idIndonesian
Ansuvimab
itItalian
Ansuvimab
zhChinese
安舒韦单抗

Popularity rank trends

Best Rank Indonesian:
#358988
02.2025
Global:
#328174
03.2020

AI rank trends

Best Rank Indonesian:
#7187
02.2025
Global:
#50445
08.2019

Local AI rank history

Languages comparison

Important global interconnections (July 2024 – June 2025)

Wikipedia readers most often find their way to information on MAb114 from Wikipedia articles about Ebola hemorrhagic fever, World Health Organization Model List of Essential Medicines, ZMapp, Nancy Sullivan and Jean-Jacques Muyembe-Tamfum. Whereas reading the article about MAb114 people most often go to Wikipedia articles on Monoclonal antibody, Atoltivimab/maftivimab/odesivimab, ZMapp, Zaire ebolavirus and Ebola hemorrhagic fever.

Cumulative results of quality and popularity of the Wikipedia article

List of Wikipedia articles in different languages (starting with the most popular):

News from 21 February 2026

On 21 February 2026 in multilingual Wikipedia, Internet users most often read articles on the following topics: Jeffrey Epstein, Alysa Liu, Eric Dane, 2026 Winter Olympics, Rebecca Gayheart, Johannes Høsflot Klæbo, Wuthering Heights, amyotrophic lateral sclerosis, Andrew Mountbatten-Windsor, John F. Kennedy Jr..

In Indonesian Wikipedia the most popular articles on that day were: XNXX, MasterChef Indonesia (musim 13), Dewan Perdamaian, Istiqomah Cinta, Low Tuck Kwong, Indonesia, Hidangan Indonesia, Mustafa Kemal Atatürk, YouTube, Jeffrey Epstein.

About WikiRank

The WikiRank project is intended for automatic relative evaluation of the articles in the various language versions of Wikipedia. At the moment the service allows to compare over 44 million Wikipedia articles in 55 languages. Quality scores of articles are based on Wikipedia dumps from July, 2025. When calculating current popularity and AI of articles data from June 2025 was taken into account. For historical values of popularity and AI WikiRank used data from 2001 to 2025... More information